Naltrexone SR and Fluoxetine Combination Therapy in Subjects With Obsessive-Compulsive Disorder

Clinical trial NCT00758966 · TERMINATED

Trial details

NCT number: NCT00758966
Sponsor: Orexigen Therapeutics, Inc
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Obsessive-Compulsive Disorder

Start date: 2008-09-01
Primary completion: 2008-12-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.